ICE vs ZYME · P/E 37, rev $12.64B vs rev $76.3M
Intercontinental Exchange Inc (ICE) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the ICE and ZYME stock pages for the full models.
Not investment advice.